M

Medicamen Biotech Limited

(NSE: MEDICAMEQ)

MEDICAMEQ

738.9

1.90 (0.26%)

Price Chart

Price Chart

Price Summary

Today’s High

749.1

Today’s Low

726.4

52 Week's High

749.1

52 Week's Low

726.4

Company Essentials

Market Cap

873.6 Cr

CASA

0.0

No. Of Shares

1.2 Cr

P/E

52.2

P/B

5.1

Face Value

10.0

Dividend Yeild

0.2

Book Value

104.5

Net Interest Income

15.33 L

Cost to Income

NA

Promoter Holdings

43.6

EPS

10.2

CAR

NA

ROE

10.1

ROCE

13.1

Profit Growth

NA

Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Medicamen Biotech Limited

735.45

873

5.1

52.2

10.2

10.1

13.1

15.33 L

RPG Life Sciences Limited

716.9

881

3.0

16.0

24.2

20.4

27.2

32.0

SMS Pharmaceuticals Limited

81.3

831

2.5

17.3

7.2

15.3

17.1

31.4

Bliss GVS Pharma Limited

77.8

820

1.4

15.1

6.5

9.4

11.8

1.1K

Themis Medicare Limited

823.1

816

1.4

9.7

29.0

15.5

17.0

41.2

Jagsonpal Pharmaceuticals Limited

387.45

813

1.8

12.2

6.5

15.7

19.4

299.2

FAQ’s on Medicamen Biotech Limited

About

Medicamen Biotech Limited was incorporated in December 1993, it is a widely held, Globaly Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. Medicamen Biotech Limited is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical fraternity since inception.

Medicamen Biotech started its operation as distributor and manufacturer of medicines on loan license basis. The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries.The vast distribution network with demand for low cost medicines prompted Mr. B.K. Gupta - Managing Director of the company to go for own manufacturing facilities. Thus in the later part of 1994 a land of 2,10,000 square feet in the Industrial town of Bhiwadi in the state of Rajasthan was procured.

In 1995 Medicamen Biotech Limited was enlisted in Bombay Stock Exchange and public issue was oversubscribed by more than 11 times. Within a span of 10 years Medicamen Biotech Limited is now among top 50 Indian export company.

In the year 2005 keeping the pace with the ever increasing demand and fulfilling the commitment, a second unit was installed in the Tax free zone at Haridwar in the state of Uttarakhand .The Unit II is fully operational from April 2007 with ultra modern manufacturing facilities.

Product range of the company includes:

The company is the Manufacturer and supplier of Comprehensive range of products:

  • Tablets
  • Capsules
  • Liquid Syrup
  • Dry Syrup (Beta Lactum and Non Beta Lactum)
  • Ointment
  • ORS

Achievements/ recognition:

The company is the receipents of the following certificates & awards:

  • WHO-GMP
  • ISO 9001: 2000
  • Star Export House
  • Certificate Of Merit
  • “Niryat Shree” for the four consecutive years from 2002 to 2005 from Government of India